USC/Norris Comprehensive Cancer Center
USC/Norris
About USC/Norris
Patient Care
Research
Clinical Trials
Search Trials
Faculty
Education
Future at USC/Norris
Core Facilities
Support USC/Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 1B-07-3
Description:
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated Her2-Positive Metastatic Breast Cancer.
Status:
Open
Randomized?
Yes
Researchers
Principal Investigator
Title
Darcy Spicer
M.D.
Data Management
Name
Title
Joanne Sakamoto
R.N.
Gamaliel Jacinto
D.M.
Yvonne Flores
D.M.
Jessica Levano
R.N.
You may participate in this study if:
(No criteria found)
You may not participate in this study if:
(No criteria found)
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
